Template:SubstanceBox/Psilocybin mushrooms: Difference between revisions

Line 78:

|OralROA_TimelineFile=

|OralROA_TimelineWidth=

|OralROA_Duration=[[Oral min total time::4]] - [[Oral max total time::6]] [[Oral total time units::hours]]

|OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::8]] [[Oral total time units::hours]]

|OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::45]] [[Oral onset time units::minutes]]

|OralROA_Onset=[[Oral min onset time::40]] - [[Oral max onset time::60]] [[Oral onset time units::minutes]]

|OralROA_Comeup=[[Oral min comeup time::~~1.5~~]] - [[Oral max comeup time::3]] [[Oral comeup time units::~~hours~~]]

|OralROA_Comeup=[[Oral min comeup time::50]] - [[Oral max comeup time::70]] [[Oral comeup time units::minutes]]

|OralROA_Peak=[[Oral min peak time::2]] - [[Oral max peak time::3]] [[Oral peak time units::hours]]

|OralROA_Peak=[[Oral min peak time::1.5]] - [[Oral max peak time::2]] [[Oral peak time units::hours]] <ref>{{cite journal | vauthors=((Pablo Mallaroni)), ((Natasha L. Mason )), ((Johannes T. Reckweg)), ((Riccardo Paci)), ((Sabrina Ritscher)), ((Stefan W. Toennes)), ((Eef L. Theunissen)), ((Kim P.C. Kuypers)), ((Johannes G. Ramaekers)) | journal=Clinical Pharmacology and Therapeutics | title=Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition | date= May 2023 | url=https://doi.org/10.1002/cpt.2958 | doi=10.1002/cpt.2958}}</ref>

|OralROA_Offset=[[Oral min offset time::~~1.5~~]] - [[Oral max offset time::2]] [[Oral offset time units::hours]]

|OralROA_Offset=[[Oral min offset time::3]] - [[Oral max offset time::4]] [[Oral offset time units::hours]]

|OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::24]] [[Oral afterglow time units::hours]]

}}

@@ Line 78: / Line 78: @@
       |OralROA_TimelineFile=
       |OralROA_TimelineWidth=
-      |OralROA_Duration=[[Oral min total time::4]] - [[Oral max total time::6]] [[Oral total time units::hours]]
+      |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::8]] [[Oral total time units::hours]]
-      |OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::45]] [[Oral onset time units::minutes]]
+      |OralROA_Onset=[[Oral min onset time::40]] - [[Oral max onset time::60]] [[Oral onset time units::minutes]]
-      |OralROA_Comeup=[[Oral min comeup time::1.5]] - [[Oral max comeup time::3]] [[Oral comeup time units::hours]]
+      |OralROA_Comeup=[[Oral min comeup time::50]] - [[Oral max comeup time::70]] [[Oral comeup time units::minutes]]
-      |OralROA_Peak=[[Oral min peak time::2]] - [[Oral max peak time::3]] [[Oral peak time units::hours]]
+      |OralROA_Peak=[[Oral min peak time::1.5]] - [[Oral max peak time::2]] [[Oral peak time units::hours]] <ref>{{cite journal | vauthors=((Pablo Mallaroni)), ((Natasha L. Mason )), ((Johannes T. Reckweg)), ((Riccardo Paci)), ((Sabrina Ritscher)), ((Stefan W. Toennes)), ((Eef L. Theunissen)), ((Kim P.C. Kuypers)), ((Johannes G. Ramaekers)) | journal=Clinical Pharmacology and Therapeutics | title=Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition | date= May 2023 | url=https://doi.org/10.1002/cpt.2958 | doi=10.1002/cpt.2958}}</ref>
-      |OralROA_Offset=[[Oral min offset time::1.5]] - [[Oral max offset time::2]] [[Oral offset time units::hours]]
+      |OralROA_Offset=[[Oral min offset time::3]] - [[Oral max offset time::4]] [[Oral offset time units::hours]]
       |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::24]] [[Oral afterglow time units::hours]]
 }}